Drug Discovery Services Market, By Process (Target Selection, Target Validation, Hit-to-lead Identification, Candidate Validation, and Others), By Type (Medicinal Chemistry, Biology Services, Drug Metabolism, Pharmaceutical Services, and Pharmacokinetics), By Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, and Others), By Drug Type (Small Molecules and Biologics), By Technology (High Throughput Screening, Biochips, Pharmacogenetics, Nanotechnology, and Spectroscopy), By End User (Hospital & Clinics, Pharmaceutical Companies, Biotechnology Companies, and Research Institute), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2025

Report Code: PMI422320 | Publish Date: August 2023 | No. of Pages: 147

Global Drug Discovery Services Market Overview

Drug discovery is the method of new drug designing. Random screening, molecular manipulation, drug metabolites, molecular designing, and serendipity are the most common methods employed for drug discovery. Drug discovery services are mainly developed to lower the costs and timelines of drug discovery. In biotechnology, pharmacology, and medicine, the procedure of drug discovery is applicable to design and discover new medications. Drug discovery services are an extremely important tool extensively used in forensics, disaster victim identification, paternity testing, and anthropology with DNA analysis. The drug target recognition, drug discovery selection, and drug design based on the fragment, lead compound recognition, and lead optimization form the core of drug discovery services.

Global Drug Discovery Services Market Dynamics

Major pharmaceutical companies involved in drug discovery and services are shifting their focus on attaining a significant position in developing countries such as India, China, Brazil, and Mexico in order to enlarge their business strategies and explore new markets. Developing nations in Asia Pacific are launching early-stage research programs, in order to meet the specific medical requirements of patients in the region. This is likely to drive the global drug discovery services market growth.

Lack of trained professionals

In drug discovery services is suffering from shortage of skilled staff. This shortage affects contract research organizations and biotechnological and pharmaceutical companies. There are very less number of organizations and institutions that offer training in drug discovery and informatics services all over the world. Therefore, presence of trained professionals is also low. These factors are likely to limit the drug discovery services market over the forecast period.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Drug Discovery Services Market Segmentation

 Regional Insights:

The global drug discovery services market is segmented based on process, type, therapeutic area, drug type, technology, end-user, and region.

On the basis of process, the global drug discovery services market is segmented into target selection, target validation, hit-to-lead identification, candidate validation, and others. Based on type, the target market is segmented into medicinal chemistry, biology services, drug metabolism, pharmaceutical services, and pharmacokinetics. Based on therapeutic area, the target market is segmented into oncology, neurology, cardiovascular disease, respiratory disease, diabetes, and others. Based on type, the target market is segmented into Based on drug type, the target market is segmented into small molecules and biologics. Based on technology, the target market is segmented into high throughput screening, biochips, pharmacogenetics, nanotechnology, and spectroscopy. Based on end-user, the target market is segmented into hospital & clinics, pharmaceutical companies, biotechnology companies, and research institute.

On region the global drug discovery services market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are projected to maintain their dominance over the forecast period owing to advanced health care infrastructure. The drug discovery services in Asia Pacific accounts for lucrative growth in the region owing to rapid growth rate over the forecast period. An increase in government initiatives is expected to drive the market share of Asia Pacific.

 

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2025

Market representation

Revenue in USD Million & CAGR from 2020 – 2025

Market Segmentation

By Process- Target Selection, Target Validation, Hit-to-lead Identification, Candidate Validation, and Others

By Type– Medicinal Chemistry, Biology Services, Drug Metabolism, Pharmaceutical Services, and Pharmacokinetics

By Therapeutic Area- Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, and Others

By Drug Type- Small Molecules and Biologics

By Technology- High Throughput Screening, Biochips, Pharmacogenetics, Nanotechnology, and Spectroscopy

By End-user- Hospital & Clinics, Pharmaceutical Companies, Biotechnology Companies, and Research Institute

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2025. For the purpose of this study, has segmented the global drug discovery services market report based on process, type, therapeutic area, drug type, technology, end-user, and region.

Drug Discovery Services Market, By Process:

  • Target Selection
  • Target Validation
  • Hit-to-lead Identification
  • Candidate Validation
  • Others

Drug Discovery Services Market, By Type:

  • Medicinal Chemistry
  • Biology Services
  • Drug Metabolism
  • Pharmaceutical Services
  • Pharmacokinetics

 Drug Discovery Services Market, By Therapeutic Area:

  • Oncology
  • Neurology
  • Cardiovascular Disease
  • Respiratory Disease
  • Diabetes
  • Others

 Drug Discovery Services Market, By Drug Type:

  • Small Molecules
  • Biologics

Drug Discovery Services Market, By Technology:

  • High Throughput Screening
  • Biochips
  • Pharmacogenetics
  • Nanotechnology
  • Spectroscopy

 Drug Discovery Services Market, By End-user:

  • Hospital & Clinics
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Research Institute

 Drug Discovery Services Market, By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa

Global Drug Discovery Services Market Key Players

The key players operating the global drug discovery services market includes Abbott Laboratories Inc., Agilent Technologies Ubiquigent, Advinus Therapeutics, Albany Molecular Research Inc., AstraZeneca PLC, Aurigene, Charles River Laboratories International, Bayer AG, ChemBridge Corporation, and Covance. These prominent players has established drug discovery services with a robust offering that has a projecting presence in the market. Along with the global distribution partnerships and network, which exist for these players, they will have a dominating share in the market in the coming years.

Global Drug Discovery Services Market Key Issues Addressed

  • In May 2024, Enzene Launched Drug Discovery Services Division. Enzene Biosciences, a global CDMO announces the launch of a new Drug Discovery Division. The drug discovery division further expands the CDMOs breadth of services to the biotech industry and complements its fully-connected continuous manufacturing platform (EnzeneX)-equipped biologics manufacturing site, which will open later this summer in the U.S.
  • In April 2024, Flipping the drug development industry on its head. One CRO dared to question the status quo and the results are undeniable. The development of new medication by biotech and pharmaceutical companies, from target identification to marketing approval, is a time-consuming process with timelines extending to 12 years or more. Hence why sponsors are opting to outsource research and development (R&D) of their novel drug products to contract research organizations (CROs).
  • In December 2023, Merck Launched First Ever AI Solution to Integrate Drug Discovery and Synthesis. The system utilizes AI, machine learning, and computer-aided drug design to enhance drug success rates, screen compounds from over 60 billion targets, evaluate synthesis routes, and recommend reagents and building blocks.

Global Drug Discovery Services Market Company Profile

  • Abbott Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Agilent Technologies Ubiquigent
  • Advinus Therapeutics
  • Albany Molecular Research Inc.
  • AstraZeneca PLC
  • Aurigene
  • Charles River Laboratories International
  • Bayer AG
  • ChemBridge Corporation
  • Covance

 “*” marked represents similar segmentation in other categories in the respective section.

Global Drug Discovery Services Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for Drug Discovery Services Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Process
      • Market Snippet, By Type
      • Market Snippet, By Therapeutic Area
      • Market Snippet, By Drug Type
      • Market Snippet, By Technology
      • Market Snippet, By End-user
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Process, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Target Selection
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Target Validation
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Hit-to-lead Identification
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Candidate Validation
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Market Segmentation, By Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Medicinal Chemistry
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Biology Services
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Drug Metabolism
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Pharmaceutical Services
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Pharmacokinetics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Market Segmentation, By Therapeutic Area, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Oncology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Neurology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cardiovascular Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Respiratory Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Diabetes
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Market Segmentation, By Drug Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Small Molecules
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Biologics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  9. Market Segmentation, By Technology, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • High Throughput Screening
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Biochips
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Pharmacogenetics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Nanotechnology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Spectroscopy
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  10. Market Segmentation, By End-user, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospital & Clinics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Pharmaceutical Companies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Biotechnology Companies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Research Institute
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  11. Global Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Process, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Area, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Process, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Area, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Process, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Area, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Process, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Area, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size  and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Process, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Therapeutic Area, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  12. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  13. Company Profiles
      • Abbott Laboratories Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • Agilent Technologies Ubiquigent
      • Advinus Therapeutics
      • Albany Molecular Research Inc.
      • AstraZeneca PLC
      • Aurigene
      • Charles River Laboratories International
      • Bayer AG
      • ChemBridge Corporation
      • Covance
  14. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The Global Drug Discovery Services market is segmented into basis of process, type, therapeutic area, drug type, technology, end-user, and region.

Major pharmaceutical companies involved in drug discovery and services are shifting their focus on attaining a significant position in developing countries such as India, China, Brazil, and Mexico in order to enlarge their business strategies and explore new markets.

By region, North America and Europe are projected to maintain their dominance over the forecast period owing to advanced health care infrastructure.

The Key players operating in the global Drug Discovery Services market include Abbott Laboratories Inc., Agilent Technologies Ubiquigent, Advinus Therapeutics, Albany Molecular Research Inc., AstraZeneca PLC, Aurigene, Charles River Laboratories International, Bayer AG, ChemBridge Corporation, and Covance.